Cyclin-dependent kinases in brain development and disease
- PMID: 21740229
- DOI: 10.1146/annurev-cellbio-092910-154023
Cyclin-dependent kinases in brain development and disease
Abstract
Cyclin-dependent kinase 5 (Cdk5) is a multifaceted serine/threonine kinase protein with important roles in the nervous system. Two related proteins, p35 and p39, activate Cdk5 upon direct binding. Over the past decade, Cdk5 activity has been demonstrated to regulate many events during brain development, including neuronal migration as well as axon and dendrite development. Recent evidence also suggests a pivotal role for Cdk5 in synaptic plasticity, behavior, and cognition. Dysfunction of Cdk5 has been implicated in a number of neurological disorders and neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Niemann-Pick type C disease, and ischemia. Hyperactivation of Cdk5 due to the conversion of p35 to p25 by the calcium-dependent protease calpain during neurotoxicity also contributes to the pathological state. This review surveys recent literature surrounding Cdk5 in synaptic plasticity and homeostasis, with particular emphasis on Cdk5 kinase activity under neurodegenerative conditions.
Similar articles
-
[Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].Sheng Li Xue Bao. 2010 Aug 25;62(4):295-308. Sheng Li Xue Bao. 2010. PMID: 20717630 Review. Chinese.
-
The role of CDK5/P25 formation/inhibition in neurodegeneration.Drug News Perspect. 2006 Oct;19(8):453-60. doi: 10.1358/dnp.2006.19.8.1043961. Drug News Perspect. 2006. PMID: 17160145 Review.
-
Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory.J Neurochem. 2006 Oct;99(2):353-70. doi: 10.1111/j.1471-4159.2006.04040.x. J Neurochem. 2006. PMID: 17029592 Review.
-
Alternative roles for Cdk5 in learning and synaptic plasticity.Biotechnol J. 2007 Aug;2(8):941-8. doi: 10.1002/biot.200700093. Biotechnol J. 2007. PMID: 17597494 Review.
-
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.Biotechnol J. 2007 Aug;2(8):978-87. doi: 10.1002/biot.200700057. Biotechnol J. 2007. PMID: 17526058 Review.
Cited by
-
Deactivation of excitatory neurons in the prelimbic cortex via Cdk5 promotes pain sensation and anxiety.Nat Commun. 2015 Jul 16;6:7660. doi: 10.1038/ncomms8660. Nat Commun. 2015. PMID: 26179626 Free PMC article.
-
Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology.Cereb Cortex. 2016 Jul;26(7):2937-51. doi: 10.1093/cercor/bhv032. Epub 2015 Jun 17. Cereb Cortex. 2016. PMID: 26088971 Free PMC article.
-
Structural insights into the functional diversity of the CDK-cyclin family.Open Biol. 2018 Sep;8(9):180112. doi: 10.1098/rsob.180112. Open Biol. 2018. PMID: 30185601 Free PMC article. Review.
-
Analysis of Cdk5-related phosphoproteomics in growth cones.J Mol Neurosci. 2014 Mar;52(3):384-91. doi: 10.1007/s12031-013-0162-x. J Mol Neurosci. 2014. PMID: 24234032
-
Inhibition of Cdk5 in PV Neurons Reactivates Experience-Dependent Plasticity in Adult Visual Cortex.Int J Mol Sci. 2021 Dec 24;23(1):186. doi: 10.3390/ijms23010186. Int J Mol Sci. 2021. PMID: 35008611 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
